Biohaven (BHVN) Stock Maintains Buy Rating After SK Deal

Biohaven (BHVN) retains a Buy rating from TD Cowen following its recent agreement with SK Holdings. The firm commented on Biohaven's strategic direction and potential growth following the deal, though specific financial details were not disclosed. This endorsement suggests confidence in Biohaven's future performance, potentially influencing investor sentiment positively. A strong recommendation can be pivotal for stock price momentum, making it essential for investors to monitor Biohaven's developments closely.